Neuronal Ceroid Lipofuscinosis: FDA Expands Indication of BioMarin’s Brineura for Children
Neuronal ceroid lipofuscinosis type 2 (CLN2) disease, a rare and rapidly progressing neurodegenerative condition, now has an expanded treatment option for young children. The...
Sensors Recall: Abbott Recalls Small Number of FreeStyle Libre 3 Sensors
Sensors for continuous glucose monitoring (CGM) are critical for managing diabetes, providing users with real-time data to make informed decisions about their health. Abbott...
Alopecia Areata: U.S. FDA Approves LEQSELVI™ (deuruxolitinib), an Oral JAK Inhibitor for Severe Cases
Alopecia Areata, a common autoimmune disease characterized by sudden hair loss on the scalp, face, and other areas of the body, affects around 700,000...
Technology Focus: HHS Reorganizes Technology, Cybersecurity, Data, and Artificial Intelligence Strategy and Policy Functions
Technology advancements in healthcare have significantly shaped the landscape of health services in recent years. The U.S. Department of Health and Human Services (HHS)...
Health Achievements: Korea Health Industry Development Institute Excels in Ministry of Health and Welfare Management Evaluation
Health advancements have been a cornerstone for the Korea Health Industry Development Institute (NECA), which has been recognized for its excellence in improving advanced...
Ovarian Cancer Survivors Show Lower Risk of Developing Breast Cancer, Study Finds
Ovarian cancer is a severe and often life-threatening condition, particularly for women with faulty BRCA genes, which significantly increase the risk of various cancers....
Hand Eczema: LEO Pharma Receives Positive CHMP Opinion of Anzupgo® (delgocitinib cream) for Treatment of Adults
Hand eczema is a chronic, inflammatory skin condition that significantly impacts the quality of life of those affected, manifesting in symptoms such as itching,...
Fixation: FDA Clears Camber Spine’s SPIRA-A Integrated Fixation System
Fixation devices play a critical role in spinal surgeries, ensuring stability and facilitating successful outcomes. The SPIRA-A Integrated device, recently cleared by the FDA,...
Approval: Strata Skin’s XTRAC Momentum 1.0 Laser Secures Approval in Japan
Approval of the XTRAC Momentum 1.0 laser system by Japan’s Ministry of Health, Labor, and Welfare marks a significant milestone for STRATA Skin Sciences....
Mental Health and Substance Use Services Expanded with $45.1 Million in Grants
Mental health is the focus as the U.S. Department of Health and Human Services (HHS), through the Substance Abuse and Mental Health Services Administration...
